Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Todays Announcement Goblet Expansion

<< Previous

Bullboard Posts

Next >>

Comment by Noteableon May 09, 2024 2:03pm

65 Views

Post# 36031694

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Todays Announcement Goblet Expansion

Trump's violation of the US Insurrection Act .. see 2022 link.

Trump’s legal duty closely resembled a police officer’s. His duty, however, was imposed by Article II, Section 3 of the Constitution, which provides: “[The president] shall take Care that the Laws be faithfully executed.” He violated his duty under the Constitution and in so doing, under the Insurrection Act.

https://www.justsecurity.org/82696/trump-and-the-insurrection-act-the-true-legal-framework/

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?